Search Results - "Cano, Maria V."
-
1
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018
Published in Vaccine (29-01-2021)“…Myopericarditis after vaccination has been sporadically reported in the medical literature. Here, we present a thorough descriptive analysis of reports to a…”
Get full text
Journal Article -
2
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016
Published in Journal of allergy and clinical immunology (01-04-2019)“…Anaphylaxis, a rare and potentially life-threatening hypersensitivity reaction, can occur after vaccination. We sought to describe reports of anaphylaxis after…”
Get full text
Journal Article -
3
Safety of the 9-Valent Human Papillomavirus Vaccine
Published in Pediatrics (Evanston) (01-12-2019)“…The 9-valent human papillomavirus vaccine (9vHPV) was approved for females and males aged 9 to 26 years in 2014. We analyzed postlicensure surveillance reports…”
Get full text
Journal Article -
4
Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010–2017
Published in Vaccine (29-01-2020)“…Vaccines administered into or too close to underlying joint structures have the potential to cause shoulder injuries. Limited data exist on the epidemiology of…”
Get full text
Journal Article -
5
Adverse events after vaccination among HIV-positive persons, 1990-2016
Published in PloS one (19-06-2018)“…Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to vaccines in infected persons. We investigated if unexpected…”
Get full text
Journal Article -
6
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017
Published in Vaccine (11-02-2020)“…•VAERS received 1086 reports of EM/SJS/TEN during 1999–2017, mostly EM (984, 91%).•Most reports of SJS or TEN (52–100%), but few reports of EM (9%), were…”
Get full text
Journal Article -
7
Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011–July 2018
Published in Vaccine (16-10-2019)“…In March 2011, the U.S. Food and Drug Administration licensed adenovirus type 4 and type 7 vaccine, live, oral (Barr Labs, Inc.) (adenovirus vaccine) for use…”
Get full text
Journal Article -
8
Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010–2015
Published in Vaccine (27-03-2017)“…Abstract Background Limited data are available describing the post-licensure safety of meningococcal vaccines, including Menveo®. We reviewed reports of…”
Get full text
Journal Article -
9
Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018
Published in Vaccine (21-01-2022)“…Bexsero® (GlaxoSmithKline) is a four-component Neisseria meningitidis serogroup B vaccine (MenB-4C). It was licensed in the United States in 2015 for use among…”
Get full text
Journal Article -
10
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016
Published in Vaccine (11-09-2020)“…Post marketing safety evaluations of quadrivalent meningococcal diphtheria-toxoid conjugate vaccine (MenACWY-D) have focused on post-vaccination risk of…”
Get full text
Journal Article -
11
Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015
Published in Vaccine (25-01-2018)“…•Study included VAERS Hepatitis B reports from January 2005–December 2015.•Most reports (15,787, 78%), were following combination vaccines.•No new or…”
Get full text
Journal Article -
12
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
Published in MMWR. Morbidity and mortality weekly report (01-02-2019)“…Recombinant zoster vaccine (RZV; Shingrix), an adjuvanted glycoprotein vaccine, was licensed by the Food and Drug Administration (FDA) and recommended by the…”
Get full text
Journal Article Newsletter -
13
-
14
Administration Error Involving a Meningococcal Conjugate Vaccine — United States, March 1, 2010–September 22, 2015
Published in MMWR. Morbidity and mortality weekly report (19-02-2016)“…Su et al report on administration error involving Menveo, a conjugate vaccine that was recommended in October 2010 for routine use in adolescents to prevent…”
Get full text
Journal Article Newsletter -
15
Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine - United States, 2017
Published in MMWR. Morbidity and mortality weekly report (26-01-2018)Get full text
Journal Article -
16
Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine - United States, 2017-2018
Published in MMWR. Morbidity and mortality weekly report (25-05-2018)Get full text
Journal Article -
17
Administration of Expired Injectable Influenza Vaccines Reported to the Vaccine Adverse Event Reporting System — United States, July 2018–March 2019
Published in MMWR. Morbidity and mortality weekly report (14-06-2019)Get full text
Journal Article Newsletter -
18
A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001
Published in The American journal of tropical medicine and hygiene (01-12-2003)“…During spring 2001, college students from Pennsylvania reported an acute febrile respiratory illness after returning from spring break vacation in Acapulco,…”
Get more information
Journal Article -
19
Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine--United States, March 1, 2010-September 22, 2015
Published in MMWR. Morbidity and mortality weekly report (19-02-2016)“…Menveo (GlaxoSmithKline, previously Novartis AG) is a conjugate vaccine that was recommended in October 2010 for routine use in adolescents (preferably aged 11…”
Get full text
Journal Article -
20
Vaccine Administration Errors Involving Recombinant Zoster Vaccine — United States, 2017–2018
Published in MMWR. Morbidity and mortality weekly report (25-05-2018)Get full text
Journal Article Newsletter